News | January 25, 2010

Study Initiated for Minimally Invasive Aortic Valve Surgery System

January 25, 2010 – First-in-man procedures and a feasibility study in Europe were recently initiated for a new minimally invasive aortic valve surgery system.

The study, TRITON, will test the Odyssey aortic valve replacement system. It is part of Edwards Lifesciences’ strategy to marry its expertise in heart valves with innovations in delivery to improve the valve surgery experience for both surgeons and their patients.

"The investigational Odyssey aortic valve replacement system is designed to enable surgeons to rapidly deploy a heart valve that offers excellent hemodynamics and proven durability, without requiring a traditional sutured approach. This is a great step forward for patients who are not high risk enough to qualify for transapical valve replacement, yet are seeking a less-invasive option," said Axel Haverich, M.D., whose team performed the first successful implants of the new system. Dr. Haverich is head of the department of cardiothoracic transplantation and vascular surgery at Hannover Medical School in Germany and provides paid consulting services to Edwards Lifesciences for research and development of products and services for heart valve replacement.

The Project Odyssey system leverages the design of the Carpentier-Edwards PERIMOUNT Magna Ease tissue heart valve to create a new valve platform with an innovative delivery and attachment system. It is designed to enable a faster procedure, shorter patient time on cardiopulmonary bypass and a smaller incision. The feasibility study for Project Odyssey, TRITON, is now is actively enrolling at several European sites.

For more information:

Related Content

Medtronic Announces Global Resolute Onyx DES One-Month DAPT Study
News | Antiplatelet and Anticoagulation Therapies| August 18, 2017
Medtronic plc announced a global randomized clinical trial that will evaluate one-month dual antiplatelet therapy (DAPT...
Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study| August 16, 2017
Aug. 16, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking Clinic
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Abbott Initiates First Clinical Trial of Clip-Based Tricuspid Repair System
News | Heart Valve Technology| August 09, 2017
Abbott announced that the first patient has been enrolled in a clinical study to evaluate a minimally invasive clip-...
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Overlay Init